Ivermectin cream for rosacea

Publisher website
Google Scholar
Abstract
Rosacea is a chronic facial skin disease that mainly occurs in people aged over 30 years. It is common, with an estimated incidence of 1·7 per 1,000 person-years in general practice in the UK.1,2 Rosacea can cause embarrassment, anxiety, low self-esteem and lack of confidence.3 A new topical treatment has become available for the treatment of one of the clinical subtypes of rosacea. Ivermectin 10mg/g (1%) cream (Soolantra—Galderma) has received marketing authorisation for the treatment of inflammatory lesions of papulopustular rosacea in adults.4 Here we review the safety and effectiveness of ivermectin cream in the treatment of rosacea and assess how it compares with standard therapies.

This publication has 8 references indexed in Scilit: